75 related articles for article (PubMed ID: 5164808)
1. Biodegradations of the hydroxamic acid group of p-n-butoxyphenylacethydroxamic acid (bufexamac) in various animal species.
Roncucci R; Simon MJ; Lambelin G; Buu-Hoï NP
Xenobiotica; 1971; 1(4):567-8. PubMed ID: 5164808
[No Abstract] [Full Text] [Related]
2. Elimination of 4-n-butoxyphenylacethydroxamic acid (bufexamac) in man.
Boreham DR; Cummings AJ; Della D; Martin BK
J Pharm Sci; 1972 Feb; 61(2):164-8. PubMed ID: 4551072
[No Abstract] [Full Text] [Related]
3. Intestinal absorption of p-butoxyphenylacethydroxamic acid and of p-butoxyphenylacetamide. In vitro studies on different segments of rat intestine.
Roncucci R; Simon MJ; Lambelin G; Gillet C; Thiriaux J; Buu-Hoï NP
Arch Int Pharmacodyn Ther; 1967 Jun; 167(2):260-4. PubMed ID: 6058775
[No Abstract] [Full Text] [Related]
4. Separation and identification of urinary metabolites of 14C-p-n-butoxyphenylacethydroxamic acid in man.
Roncucci R; Simon MJ; Lambelin G; Thiriaux J; Buu-Hoi NP
Biochem Pharmacol; 1968 Feb; 17(2):187-94. PubMed ID: 5647045
[No Abstract] [Full Text] [Related]
5. Oxidation of polycyclic N-arylacetamides to glycolamides and hydroxamic acids in rabbits.
Fries W; Kiese M; Lenk W
Xenobiotica; 1973 Aug; 3(8):525-40. PubMed ID: 4128672
[No Abstract] [Full Text] [Related]
6. Gas-liquid chromatography of hydroxamic acids in biological samples. Detection and quantitation of Bufexamac and one of its major metabolites in plasma and urine.
Roncucci R; Simon MJ; Lambelin G
J Chromatogr; 1971 May; 57(3):410-2. PubMed ID: 5091949
[No Abstract] [Full Text] [Related]
7. Use of bufexamac suppositories in rectal conditions.
Samsi AB
J Postgrad Med; 1975 Jul; 21(3):131-4. PubMed ID: 1206602
[No Abstract] [Full Text] [Related]
8. [Results of a study of the resorption of bufexamac following rectal administration].
Glowania HJ; Hampl B
Z Hautkr; 1988 Mar; 63(3):211. PubMed ID: 3388925
[TBL] [Abstract][Full Text] [Related]
9. [Bufexamac, non-steroid anti-inflammatory agent utilizable locally in clinical dermatology].
Achten G; Bourlond A; Haven E; Lapiere C; Pierard J; Reynaers H
Arch Belg Dermatol Syphiligr; 1970; 26(4):509-10. PubMed ID: 5512147
[No Abstract] [Full Text] [Related]
10. Physiologic disposition of short chain aliphatic hydroxamates in the mouse. II. Absorption, distribution, metabolism and excretion of 1- 14C-acetohydroxamic acid.
Fishbein WN; Streeter CL; Daly J
J Pharmacol Exp Ther; 1973 Jul; 186(1):173-82. PubMed ID: 4723309
[No Abstract] [Full Text] [Related]
11. [Clinical study of topically administered bufexamac in general practice].
Mathieu R
Schweiz Rundsch Med Prax; 1971 Nov; 60(47):1577-8. PubMed ID: 5140890
[No Abstract] [Full Text] [Related]
12. [Treatment of superficial phlebitis with Bufexamac cream. Cooperative study carried out by 195 physicians with 564 patients].
Reynaers H
Arch Belg Dermatol Syphiligr; 1972; 28(3):279-86. PubMed ID: 4578358
[No Abstract] [Full Text] [Related]
13. Methylmercapto-4-acetylaminostilbenes as products of the reaction of n-acetoxy-4-acetylaminostilbene with methionine and as degradation products of liver protein from rats given n-hydroxy-4-acetylaminostilbene.
Miller EC; Butler BW; Fletcher TL; Miller JA
Cancer Res; 1974 Sep; 34(9):2232-9. PubMed ID: 4843530
[No Abstract] [Full Text] [Related]
14. [Bufexamac cream and ointment for the treatment of various dermatoses].
Achten G; Bourlond A; Haven E; Lapière CM; Piérard J; Reynaers H
Dermatologica; 1973; 146(1):1-7. PubMed ID: 4571591
[No Abstract] [Full Text] [Related]
15. [Study on metabolism of alpha, alpha-diethyl-3,4-methylenedioxyphenylacetamide (Hoe 264) in guinea pigs].
Volz M
Arzneimittelforschung; 1973 Aug; 23(8):1024-7. PubMed ID: 4801019
[No Abstract] [Full Text] [Related]
16. Comparative study of bufexamac (Droxaryl) ointment and of its excipient on psoriasis cases: double-blind test.
Van der Meersch J
Curr Ther Res Clin Exp; 1974 Sep; 16(9):904-8. PubMed ID: 4214665
[No Abstract] [Full Text] [Related]
17. [Preliminary study of the action of p-butoxyphenylacethydroxamic acid (Bufexamac) in the treatment of coxarthrosis].
Bloch-Michel H; Parrot M
Therapie; 1970; 25(5):969-75. PubMed ID: 5486155
[No Abstract] [Full Text] [Related]
18. The metabolism of homoanisic acid in man and guinea pigs.
Oakley SE; Seakins JW
Biochem J; 1971 Jan; 121(1):17P-18P. PubMed ID: 5116533
[No Abstract] [Full Text] [Related]
19. Metabolic patterns of 4-allyloxy-3-chlorophenylacetic acid in rat, rabbit, dog, monkey, and man.
Roncucci R; Simon MJ; Lambelin G; Gillet C; Staquet M; Buu-Hoï NP
Arzneimittelforschung; 1970 May; 20(5):631-6. PubMed ID: 4987566
[No Abstract] [Full Text] [Related]
20. Physiologic disposition of short chain aliphatic hydroxamates in the mouse. I. The one-through-four carbon hydroxamates: excretion and conversion to amides.
Fishbein WN; Streeter CL
J Pharmacol Exp Ther; 1970 Aug; 174(2):239-46. PubMed ID: 5451361
[No Abstract] [Full Text] [Related]
[Next] [New Search]
